《Malignant Melanoma: Biology, Diagnosis, and Therapy》是一本圖書。
基本介紹
- 外文名:Malignant Melanoma: Biology, Diagnosis, and Therapy
- ISBN:9781461289838
《Malignant Melanoma: Biology, Diagnosis, and Therapy》是一本圖書。
眼瞼惡性黑色素瘤 眼瞼惡性黑色素瘤(malignant melanoma of eyelid)是2017年公布的老年醫學名詞。定義 位於眼瞼的藍黑色小結節。周圍血管擴張,可形成潰瘍出血,惡性度高,容易轉移。出處 《老年醫學名詞》第一版。
心臟轉移性惡性黑色素瘤(cardiac metastatic malignant melanoma)於1867年Prudhomme首次報導,之後隨著診斷技術的進步和屍檢工作加強,報導病例數逐漸增多。黑色素瘤向心臟轉移的發生率是僅次於肺癌、淋巴癌和乳腺癌之後的第四大病源。心臟受累常常是黑色素瘤廣泛轉移的一部分。病因 在所有的惡性腫瘤中最易發生心臟轉移的...
《Rap1GAP抑制惡性黑色素瘤血管形成作用機制的探討》是依託華中科技大學,由鄭鴻擔任項目負責人的面上項目。中文摘要 血管形成是惡性黑色素瘤(Malignant melanoma,MM)生長及轉移的病理基礎和重要條件,如何抑制MM血管形成是目前亟待突破的關鍵問題。申報者在原有Rap1GAP抑制MM細胞作用研究的基礎上,進一步發現Rap1GAP...
肛管直腸惡性黑色素瘤(anorectal malignant melanoma , AMM )由Moore(1857)首次報導,是一種少見且預後極差的腫瘤,具有很強的侵襲性和轉移性,臨床極易誤診。肛管直腸黑色素瘤占全部惡性黑色素瘤的l %一2 %,占大腸腫瘤的0 . 1 % ? 1 . 9 % ,占肛管惡性腫瘤的0 . 25 % ? 2 . 5 %。好發於50...
外陰惡性黑色素瘤與其他部位的黑色素瘤生物學行為方面顯著不同,預後也顯著差於後者。惡性黑色素瘤是來自於神經嵴黑色素細胞且較少見的惡性腫瘤。黑色素細胞主要位於皮膚表皮,鑲嵌於基底細胞之間,因此惡性黑色素瘤好發於皮膚及近皮膚的黏膜。病因 外陰惡性黑色素瘤常來源於結合痣或複合痣。儘管有一些外陰惡性黑色素瘤...
The downstream integration nightmare is avoided, along with late patches and malignant software fixes. 順流而下的集成噩夢被避免了,同時避免的還有以後的補丁和軟體修正。Of those 60,000 deaths, an estimated 48,000 are caused by malignant melanomas, and 12,000 by skin carcinomas. 在這6萬死亡中,...
12About 68, 000 cases of melanoma will be diagnosed in Americans this year alone.單單在今年,美國就有68000例黑素瘤被確診。13They include breast, bowel, ovarian and skin cancer, leukaemia and malignant melanoma.這些癌症包括乳腺癌、直腸癌、卵巢癌、皮膚癌、白血病和惡性黑色素瘤。14More than 68, ...
2 Cancer Targeting Gene-Viro-Therapy and Its PromisingFuture 3 Relationship Between Antiproliferative Activities and Class IMHC Surface Expression of Mouse Interferon Proteins on B16-Fl0Melanoma Cells 4 Mitotic Regulator Hecl as a Potential Target for CancerTherapy 5 A...
惡性黑素瘤(Malignant melanoma簡稱惡黑)為起源於黑素細胞的惡性腫瘤,多發生於皮膚,其發病占皮膚惡性腫瘤的第三位。臨床表現 1.惡性雀斑樣痣黑素瘤(Lentigo maligna melanoma) 系從惡性雀斑樣痣發展而來,通常在惡性雀斑樣痣多年以後,皮疹擴大,出現藍黑色結節和潰瘍,多見於老年人面部。 2.淺表擴散性黑素瘤...
惡性黑素瘤(malignant melanoma)亦稱黑色素瘤(melanoma)或黑色素癌 (melanocarcinoma)。惡性黑素瘤可發生於皮膚亦可發生於黏膜。具有一定的種族特性,白種人最易發生皮膚惡性黑素瘤,而黃種人(例如日本、中國)以及黑人(例如烏干達)則以黏膜惡性黑素瘤最為常見。在皮膚癌瘤中惡性黑素瘤居第3位。惡性黑素瘤可分為4...
食管惡性黑[色]素瘤 食管惡性黑[色]素瘤(malignant melanoma of esophagus)是1997年公布的醫學名詞。出處 《醫學名詞 第六分冊》。公布時間 1997年,經全國科學技術名詞審定委員會審定發布。
因習慣對淋巴瘤(lymphoma)、黑色素瘤(malignant melanoma)和精原細胞瘤(seminoma)省去了惡性二字,但仍代表其為惡性腫瘤。瘤病(-omatosis)常用於多發性良性腫瘤,如神經纖維瘤病(neurofibromatosis);或用於在局部呈瀰漫性生長的良性腫瘤,如纖維瘤病(fibromatosis)、脂肪瘤病(lipomatosis)和血管瘤病(angiomatosis)。
結節性惡性黑[色]素瘤 結節性惡性黑[色]素瘤(nodular malignant melanoma)是2002年公布的醫學名詞。公布時間 2002年,經全國科學技術名詞審定委員會審定發布。出處 《醫學名詞 第七分冊》。
The Melanocytic Proliferation describes the pathobiology of pigmented melanocytic lesions, and provides guidelines for their diagnosis and management as they affect the skin and mucosas. Extensively illustrated, this book is divided into four parts: the biology of melanocytes and malignant melanoma; nonme...
比如不典型(發育不良)痣或黑色素瘤家族史、光導致色素沉著的皮膚、不容易曬黑皮膚、紅色頭髮人種、強的間斷日光暴露、日曬傷、多發黑色素細胞痣等。基因/環境多種因素導致黑素瘤惡性轉化。惡性轉化的關鍵細胞通路:Rb通路、p53通路、PI3K/AKT通路、RAS/MAPK通路(20~30%NRAS突變,55~60%BRAF突變)。臨床表現 皮...
1.MOG-IgG associated demyelination induced by pembrolizumab treatment in a patient with malignant melanoma---《Neurology》2.術前Hook-wire 導絲定位的肺部磨玻璃結節臨床病理特徵分析---《中國臨床解剖學雜誌》3. miR-577 suppresses cell proliferation and epithelial-mesenchymal transition by regulating the WNT...
C, Wang Z, Wang X*. Notch-1 signaling facilitates survivin expression in human non-small cell lung cancer cells.Cancer Biol Ther.Gao SB, Feng ZJ, Xu B, Chen Y, Zheng HH,Yin P, Hua X*, Jin GH*. Meninrepressesmalignantphenotypesofmelanomathroughregulatingmultiplepathways.J Cell Mol Med.
15. Pu Wang, Pei-Pei Guan, Su Xu, Zhan-You Wang, Sadako Yamagata, and Tatsuya Yamagata. Emerging GM3 Regulated Biomarkers in Malignant Melanoma. Recent Advances in the Biology, Therapy and Management of Melanoma, Dr. Lester Davids (Ed.), 2013, ISBN: 978-953-51-0976-1, InTech, DOI: ...
Becker 痣(Becker Nevus)普通藍痣(Common Blue Nevus)發育不良痣(Dysplastic Nevus)Spitz 痣(Spitz Nevus)惡性雀斑樣痣(Lentigo Maligna)惡性黑素瘤(Malignant Melanoma)老年性黑子(Lentigo Senilis)脂溢性角化病(Seborrheic Keratoses)Leser-Trélat 征(Leser-Trélat Sign)黑素棘皮瘤(Melanoacanthoma)
David M. Su, Qiuyang Zhang, Xuexi Wang, Ping He, Yuelin Jack Zhu, Jianxiong Zhao, Owen M. Rennert, Yan A. Su. Two types of human malignant melanoma cell lines revealed by expression patterns of mitochondrial and survival-apoptosis genes: implications for malignant melanoma therapy. Mol ...
3. Chi Z, Li S, Sheng X, Si L, Cui C, Han M, Guo Jun. Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: A study of 522 consecutive cases. BMC Cancer. 2011;11:85. (IF=3.153)4. Kong Y, Si L, Zhu Y, Xu XG, Corless CL, Flaherty K, ...
【7】.Zhen Wu, Lijun Wu, Linhao Li, Shin-ichi Tashiro, Satoshi Onodera, Takashi Ikejima. p53- Mediated cell cycle arrest and apoptosis induced by shikonin via a caspase-9-dependent mechanism in Human malignant melanoma A375-S2 cells. Journal of Pharmacological Sciences, 2004, 94, 166-176....
Dan Huang, Jialin Jiang, Guan-Shen Cui, Ying Yang, Wenze Wang, Dan Guo, Menghua Dai, Junchao Guo, Taiping Zhang, Quan Liao, Yi Liu, Yong-Liang Zhao, Da-Li Han#, Yupei Zhao*, Yun-Gui Yang*, Wenming Wu*. Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progr...
Lin X.Z., Zheng W., Liu J., Zhang Y., Qin H.H., Wu H.C., Xue B., Lu Y., Shen P.P. *, Oxidative stress in malignant melanoma enhances TNF-α secretion of tumor-associated macrophages that promote cancer cell invasion. Antioxidants & Redox Signaling, 2013, 19(12): p.1337-...
Jiang G, Li RH, Sun C, Jia HY, Lei TC(通信作者), Liu YQ. Efficacy and safety between temozolomide alone and temozolomide-based double therapy for malignant melanoma: a meta-analysis. Tumour Biol. 2014, 35(1):315-22(影響因子:2.518)Luo LF, Shi Y, Zhou Q, Xu SZ, Lei TC(通信...
Part 4 Malignant Tumors of the Orbit(眶惡性腫瘤)Part 5 Malignant Tumors of the Eyelids(眼瞼惡性腫瘤)Part 6 Malignant Tumors of the Conjunctiva(結膜惡性腫瘤)Part 7 Malignant Tumor of the Globe:Ocular Melanoma(眼球惡性腫瘤:黑素瘤)Part 8 Surgical Procedures and Enucleation(眼手術和眼球剜出術)Cha...
20.Yi YM, Zhang G, Zeng J, Huang SC, Li LL, Fang R, Jiang GM, Bu XZ, Cai SH, andDu J. FAPτ-MT elicits effective antitumor response by targeting indolamine-2,3-dioxygenase in antigen presenting cells.Cancer Biology & Therapy.2011, 11(10) 1-8.(通信作者)21.Huang SC, Fang R,...
(6)Xing Y# , Wen XY#, Ding X#, Fan Jiayan#, Chai Peiwei#, Jia RB, Ge SF, Qian GX, Zhang H* (通訊作者), Fan XQ*. CANT1lncRNA triggers efficient therapeutic efficacy by correcting aberrant lncing cascade in malignant uveal melanoma. Molecular Therapy, 2017,25(5):1209-1221.(IF...